Early Diagnosis of Candidiasis in Premature Infants
Candida
Early Diagnosis of Nosocomial Candidiasis Study
38 other identifiers
observational
1,500
1 country
20
Brief Summary
This observational study evaluated the performance of new lab tests in detecting candida species fungal infections in extremely low birth weight (ELBW) infants quickly and accurately. 19 NICHD Neonatal Research Network sites enrolled 1,500 infants with birth weights ≤1,000g; 100 of these infants later tested positive for candidiasis. Blood, urine, and lumbar puncture samples were collected whenever other specimens were obtained from participants for cultures. These samples are being tested using the new methods and compared with standard culture results. Surviving study subjects completed a neurodevelopmental evaluation at 18-22 months corrected age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2004
Longer than P75 for all trials
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2004
CompletedFirst Submitted
Initial submission to the registry
April 28, 2005
CompletedFirst Posted
Study publicly available on registry
April 29, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedMarch 22, 2019
March 1, 2019
3.3 years
April 28, 2005
March 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Probability of invasive candidiasis based on new assay results
Until discharge
Determine test performance of clinical predictive model
Until discharge
Secondary Outcomes (14)
Determine test performance (sensitivity and specificity) of polymerase chain reaction (PCR) testing
Until discharge
Determine test performance of Beta-glucan assay
Until discharge
Determine test performance of Gas Chromatography Mass Spectrometry for D-arabinitol of blood samples
Until discharge
Determine test performance of Gas Chromatography Mass Spectrometry for D-arabinitol of urine samples
Until discharge
Determine test performance of the blood culture
Until discharge
- +9 more secondary outcomes
Eligibility Criteria
Infants with birth weights ≤1,000 grams
You may qualify if:
- Infants born ≤1,000g birth weight
- Infants \>72 hours old and less than 120 days old
You may not qualify if:
- Prior positive blood culture for Candida
- Evidence of congenital candidiasis
- Parents/legal guardians refuse consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (20)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
Stanford University
Palo Alto, California, 94304, United States
University of California at San Diego
San Diego, California, 92103-8774, United States
Yale University
New Haven, Connecticut, 06504, United States
University of Miami
Miami, Florida, 33136, United States
Emory University
Atlanta, Georgia, 30303, United States
Indiana University
Indianapolis, Indiana, 46202, United States
University of Iowa
Iowa City, Iowa, 52242, United States
Tufts Medical Center
Boston, Massachusetts, 02111, United States
Wayne State University
Detroit, Michigan, 48201, United States
University of New Mexico
Albuquerque, New Mexico, 87131, United States
University of Rochester
Rochester, New York, 14642, United States
Wake Forest University
Charlotte, North Carolina, 27157, United States
RTI International
Durham, North Carolina, 27705, United States
Duke University
Durham, North Carolina, 27710, United States
Cincinnati Children's Medical Center
Cincinnati, Ohio, 45267, United States
Case Western Reserve University, Rainbow Babies and Children's Hospital
Cleveland, Ohio, 44106, United States
Brown University, Women & Infants Hospital of Rhode Island
Providence, Rhode Island, 02905, United States
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, 75235, United States
University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Related Publications (5)
Benjamin DK Jr, Stoll BJ, Gantz MG, Walsh MC, Sanchez PJ, Das A, Shankaran S, Higgins RD, Auten KJ, Miller NA, Walsh TJ, Laptook AR, Carlo WA, Kennedy KA, Finer NN, Duara S, Schibler K, Chapman RL, Van Meurs KP, Frantz ID 3rd, Phelps DL, Poindexter BB, Bell EF, O'Shea TM, Watterberg KL, Goldberg RN; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010 Oct;126(4):e865-73. doi: 10.1542/peds.2009-3412. Epub 2010 Sep 27.
PMID: 20876174RESULTAdams-Chapman I, Bann CM, Das A, Goldberg RN, Stoll BJ, Walsh MC, Sanchez PJ, Higgins RD, Shankaran S, Watterberg KL, Duara S, Miller NA, Heyne RJ, Peralta-Carcelen M, Goldstein RF, Steichen JJ, Bauer CR, Hintz SR, Evans PW, Acarregui MJ, Myers GJ, Vohr BR, Wilson-Costello DE, Pappas A, Vaucher YE, Ehrenkranz RA, McGowan EC, Dillard RG, Fuller J, Benjamin DK Jr; Eunice Kennedy Shriver National Institutes of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr. 2013 Oct;163(4):961-7.e3. doi: 10.1016/j.jpeds.2013.04.034. Epub 2013 May 30.
PMID: 23726546RESULTBliss JM, Wong AY, Bhak G, Laforce-Nesbitt SS, Taylor S, Tan S, Stoll BJ, Higgins RD, Shankaran S, Benjamin DK Jr; Candida Subcommittee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Candida virulence properties and adverse clinical outcomes in neonatal candidiasis. J Pediatr. 2012 Sep;161(3):441-447.e2. doi: 10.1016/j.jpeds.2012.02.051. Epub 2012 Apr 14.
PMID: 22504098RESULTGreenberg RG, Benjamin DK Jr, Gantz MG, Cotten CM, Stoll BJ, Walsh MC, Sanchez PJ, Shankaran S, Das A, Higgins RD, Miller NA, Auten KJ, Walsh TJ, Laptook AR, Carlo WA, Kennedy KA, Finer NN, Duara S, Schibler K, Ehrenkranz RA, Van Meurs KP, Frantz ID 3rd, Phelps DL, Poindexter BB, Bell EF, O'Shea TM, Watterberg KL, Goldberg RN, Smith PB; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis. J Pediatr. 2012 Aug;161(2):264-9.e2. doi: 10.1016/j.jpeds.2012.01.053. Epub 2012 Mar 15.
PMID: 22424952RESULTWynn JL, Tan S, Gantz MG, Das A, Goldberg RN, Adams-Chapman I, Stoll BJ, Shankaran S, Walsh MC, Auten KJ, Miller NA, Sanchez PJ, Higgins RD, Cotten CM, Smith PB, Benjamin DK Jr; NICHD Neonatal Research Network. Outcomes following candiduria in extremely low birth weight infants. Clin Infect Dis. 2012 Feb 1;54(3):331-9. doi: 10.1093/cid/cir800. Epub 2011 Dec 5.
PMID: 22144537RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Abbot R. Laptook, MD
Brown University, Women & Infants Hospital of Rhode Island
- PRINCIPAL INVESTIGATOR
Michele C. Walsh, MD MS
Case Western Reserve University, Rainbow Babies and Children's Hospital
- PRINCIPAL INVESTIGATOR
Ronald N. Goldberg, MD
Duke University
- PRINCIPAL INVESTIGATOR
Barbara J. Stoll, MD
Emory University
- PRINCIPAL INVESTIGATOR
Brenda B. Poindexter, MD MS
Indiana University
- PRINCIPAL INVESTIGATOR
Abhik Das, PhD
RTI International
- PRINCIPAL INVESTIGATOR
Krisa P. Van Meurs, MD
Stanford University
- PRINCIPAL INVESTIGATOR
Ivan D. Frantz III, MD
Tufts Medical Center
- PRINCIPAL INVESTIGATOR
Waldemar A. Carlo, MD
University of Alabama at Birmingham
- PRINCIPAL INVESTIGATOR
Neil N. Finer, MD
University of California, San Diego
- PRINCIPAL INVESTIGATOR
Kurt Schibler, MD
Children's Hospital Medical Center, Cincinnati
- PRINCIPAL INVESTIGATOR
Edward F. Bell, MD
University of Iowa
- PRINCIPAL INVESTIGATOR
Shahnaz Duara, MD
University of Miami
- PRINCIPAL INVESTIGATOR
Kristi L. Watterberg, MD
University of New Mexico
- PRINCIPAL INVESTIGATOR
Dale L. Phelps, MD
University of Rochester
- PRINCIPAL INVESTIGATOR
Kathleen A. Kennedy, MD MPH
The University of Texas Health Science Center, Houston
- PRINCIPAL INVESTIGATOR
Pablo J. Sanchez, MD
University of Texas, Southwestern Medical Center at Dallas
- PRINCIPAL INVESTIGATOR
T. Michael O'Shea, MD MPH
Wake Forest University
- PRINCIPAL INVESTIGATOR
Seetha Shankaran, MD
Wayne State University
- PRINCIPAL INVESTIGATOR
Richard A. Ehrenkranz, MD
Yale University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2005
First Posted
April 29, 2005
Study Start
March 1, 2004
Primary Completion
July 1, 2007
Study Completion
December 1, 2009
Last Updated
March 22, 2019
Record last verified: 2019-03